Search Results - "Bisson, P"

Refine Results
  1. 1

    Tuberculosis and lung damage: from epidemiology to pathophysiology by Ravimohan, Shruthi, Kornfeld, Hardy, Weissman, Drew, Bisson, Gregory P

    Published in European respiratory review (31-03-2018)
    “…A past history of pulmonary tuberculosis (TB) is a risk factor for long-term respiratory impairment. Post-TB lung dysfunction often goes unrecognised, despite…”
    Get full text
    Journal Article
  2. 2

    Early mortality in adults initiating antiretroviral therapy (ART) in low- and middle-income countries (LMIC): a systematic review and meta-analysis by Gupta, Amita, Nadkarni, Girish, Yang, Wei-Teng, Chandrasekhar, Aditya, Gupte, Nikhil, Bisson, Gregory P, Hosseinipour, Mina, Gummadi, Naveen

    Published in PloS one (29-12-2011)
    “…We systematically reviewed observational studies of early mortality post-antiretroviral therapy (ART) initiation in low- and middle-income countries (LMIC) in…”
    Get full text
    Journal Article
  3. 3

    Upregulation of the Phthiocerol Dimycocerosate Biosynthetic Pathway by Rifampin-Resistant, rpoB Mutant Mycobacterium tuberculosis by BISSON, Gregory P, MEHAFFY, Carolina, BROECKLING, Corey, PRENNI, Jessica, RIFAT, Dalin, LUN, Desmond S, BURGOS, Marcos, WEISSMAN, Drew, KARAKOUSIS, Petros C, DOBOS, Karen

    Published in Journal of Bacteriology (01-12-2012)
    “…Article Usage Stats Services JB Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy by Bisson, Gregory P, Gross, Robert, Bellamy, Scarlett, Chittams, Jesse, Hislop, Michael, Regensberg, Leon, Frank, Ian, Maartens, Gary, Nachega, Jean B

    Published in PLoS medicine (01-05-2008)
    “…World Health Organization (WHO) guidelines for monitoring HIV-infected individuals taking combination antiretroviral therapy (cART) in resource-limited…”
    Get full text
    Journal Article
  8. 8

    Pyrazinamide clearance is impaired among HIV/tuberculosis patients with high levels of systemic immune activation by Vinnard, Christopher, Ravimohan, Shruthi, Tamuhla, Neo, Pasipanodya, Jotam, Srivastava, Shashikant, Modongo, Chawangwa, Zetola, Nicola M, Weissman, Drew, Gumbo, Tawanda, Bisson, Gregory P

    Published in PloS one (02-11-2017)
    “…Pyrazinamide is the main driver of sterilizing effect in the standard regimen in adults and older children, and this effect is concentration-dependent…”
    Get full text
    Journal Article
  9. 9

    Do some prefer to pay? Identifying bias against free COVID-19 tests by Baik, Yeonsoo, Bien-Gund, Cedric H., Bisson, Gregory P., Gross, Robert, Fishman, Jessica

    “…In the United States, a federal emergency program has made SARS-CoV-2 self-test kits available at no cost. It is unclear how widely free tests are preferred…”
    Get full text
    Journal Article
  10. 10

    Integrative Multi-Omics Reveals Serum Markers of Tuberculosis in Advanced HIV by Krishnan, Sonya, Queiroz, Artur T L, Gupta, Amita, Gupte, Nikhil, Bisson, Gregory P, Kumwenda, Johnstone, Naidoo, Kogieleum, Mohapi, Lerato, Mave, Vidya, Mngqibisa, Rosie, Lama, Javier R, Hosseinipour, Mina C, Andrade, Bruno B, Karakousis, Petros C

    Published in Frontiers in immunology (08-06-2021)
    “…Tuberculosis (TB) accounts for disproportionate morbidity and mortality among persons living with HIV (PLWH). Conventional methods of TB diagnosis, including…”
    Get full text
    Journal Article
  11. 11

    Pulmonary restriction predicts long-term pulmonary impairment in people with HIV and tuberculosis by Auld, Sara C, Kornfeld, Hardy, Maenetje, Pholo, Mlotshwa, Mandla, Chase, William, Vangu, Mboyo di-Tamba, Torigian, Drew A, Wallis, Robert S, Churchyard, Gavin, Bisson, Gregory P

    Published in BMC pulmonary medicine (07-01-2021)
    “…While tuberculosis is considered a risk factor for chronic obstructive pulmonary disease, a restrictive pattern of pulmonary impairment may actually be more…”
    Get full text
    Journal Article
  12. 12

    Dose-Dependent Activity of Pyrazinamide in Animal Models of Intracellular and Extracellular Tuberculosis Infections by AHMAD, Zahoor, FRAIG, Mostafa M, BISSON, Gregory P, NUERMBERGER, Eric L, GROSSET, Jacques H, KARAKOUSIS, Petros C

    Published in Antimicrobial Agents and Chemotherapy (01-04-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  13. 13

    Overestimates of survival after HAART: implications for global scale-up efforts by Bisson, Gregory P, Gaolathe, Tendani, Gross, Robert, Rollins, Caitlin, Bellamy, Scarlett, Mogorosi, Mpho, Avalos, Ava, Friedman, Harvey, Dickinson, Diana, Frank, Ian, Ndwapi, Ndwapi

    Published in PloS one (05-03-2008)
    “…Monitoring the effectiveness of global antiretroviral therapy scale-up efforts in resource-limited settings is a global health priority, but is complicated by…”
    Get full text
    Journal Article
  14. 14

    Urine colorimetry for therapeutic drug monitoring of pyrazinamide during tuberculosis treatment by Zentner, Isaac, Modongo, Chawangwa, Zetola, Nicola M., Pasipanodya, Jotam G., Srivastava, Shashikant, Heysell, Scott K., Mpagama, Stellah, Schlect, Hans P., Gumbo, Tawanda, Bisson, Gregory P., Vinnard, Christopher

    “…•The objective was to determine whether a urine test can identify tuberculosis patients with adequate serum pyrazinamide exposures.•The urine colorimetric…”
    Get full text
    Journal Article
  15. 15

    Isoniazid resistance and death in patients with tuberculous meningitis: retrospective cohort study by Vinnard, Christopher, Winston, Carla A, Wileyto, E Paul, MacGregor, Rob Roy, Bisson, Gregory P

    Published in BMJ (06-09-2010)
    “…Objective To determine whether initial isoniazid resistance is associated with death during the treatment of tuberculous meningitis.Design Retrospective cohort…”
    Get full text
    Journal Article
  16. 16
  17. 17

    The effect of TB treatment on health-related quality of life for people with advanced HIV by Opollo, V., Sun, X., Lando, R., Miyahara, S., Torres, T. S., Hosseinipour, M. C., Bisson, G. P., Kumwenda, J., Gupta, A., Nyirenda, M., Katende, K., Suryavanshi, N., Beulah, F., Shah, N. S., on behalf of the A5274 study team

    “…BACKGROUND: Study A5274 was an open-label trial of people with HIV (PLHIV) with CD4 cell count <50 cells/µL who were randomized to empirical TB treatment vs…”
    Get full text
    Journal Article
  18. 18
  19. 19

    HIV infection and glycemic response to newly initiated diabetic medical therapy by HAN, Jennifer H, CRANE, Heidi M, BELLAMY, Scarlett L, FRANK, Ian, CARDILLO, Serena, BISSON, Gregory P

    Published in AIDS (London) (23-10-2012)
    “…Type 2 diabetes (DM2) is increasingly common in HIV-infected individuals. Antiretroviral agents and chronic inflammation may adversely affect glycemic control…”
    Get full text
    Journal Article
  20. 20

    Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana by Zetola, N. M., Modongo, C., Kip, E. C., Gross, R., Bisson, G. P., Collman, R. G.

    “…BACKGROUND: Data on alcohol abuse as a risk factor for the development of multidrug-resistant tuberculosis (MDR-TB) are scarce.OBJECTIVE: To describe the…”
    Get full text
    Journal Article